Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.
James F Chmiel, Timothy R Aksamit, Sanjay H Chotirmall, Elliott C Dasenbrook, J Stuart Elborn, John J LiPuma, Sarath C Ranganathan, Valerie J Waters, Felix A Ratjen
Annals of the American Thoracic Society | Published : 2014
Airway infections are a key component of cystic fibrosis (CF) lung disease. Whereas the approach to common pathogens such as Pseudomonas aeruginosa is guided by a significant body of evidence, other infections often pose a considerable challenge to treating physicians. In Part I of this series on the antibiotic management of difficult lung infections, we discussed bacterial organisms including methicillin-resistant Staphylococcus aureus, gram-negative bacterial infections, and treatment of multiple bacterial pathogens. Here, we summarize the approach to infections with nontuberculous mycobacteria, anaerobic bacteria, and fungi. Nontuberculous mycobacteria can significantly impact the course ..View full abstract
Awarded by NIDDK NIH HHS